Mechanisms of type I interferon signaling in normal and malignant cells

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 3, 2004, Pages 156-163

  Li, Yongzhong ^a   Srivastava, Kishore K ^a   Platanias, Leonidas C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cytokines; Interferon; Malignat cells; Signaling

Indexed keywords

CBL PROTEIN; CRK LIKE PROTEIN; INTERFERON; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; DNA BINDING PROTEIN; INTERFERON RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN;

CANCER CELL; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; PROTEIN EXPRESSION; REVIEW; RNA TRANSLATION; ANIMAL; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; INTERFERON TYPE I; JANUS KINASE 1; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-TYROSINE KINASES; RECEPTORS, INTERFERON; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 14844303600     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Abramovich C., Shulman L. M., Ratoviski E., Harroch S., Tovey M., Eid P. and Revel M. (1994): Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and an associated surface protein in response to IFNα and IFNβ. EMBO. J., 13, 5871-5877.
2. Adam L., Bandyopadhyay D. and Kumar R. (2000): Interferon-α signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2. Biochem. Biophys. Res. Commun., 267, 692-696.
3. Ahmad S., Alsayed Y., Druker B. J. and Platanias L. C. (1997): The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem., 272, 29991-29994.
4. Biron C. A. (1999): Initial and innate responses to viral infections - pattern setting in immunity or disease. Curr. Opin. Microbiol., 2, 374-381.
5. Brierley M. M. and Fish E. N. (2002): IFNα/β receptor interactions to biologic outcomes: understanding the circuitry. J. Interferon Cytokine Res., 22, 835-845.
6. Bustelo X. R. (2000): Regulatory and signaling properties of the Vav family. Mol. Cell. Biol., 20, 1461-1477.
7. Cano E. and Mahadevan L. C. (1995): Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci., 20, 117-122.
8. Chou M. M. and Blenis J. (1995): The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol., 7, 806-814.
9. Clayton A. L. and Mahadevan L. C. (2003): MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEES Lett., 546, 51-58.
10. Colamonici O. R. and Domanski P. (1994): Identification of a novel subunit of the type I interferon receptor localized to chromosome 21. J. Biol. Chem., 268, 10895-10899.
11. Colamonici O. R., Pfeffer L., D'Alessandro F., Platanias L. C., Rosolen A., Nordan R., Cruciani R. A. and Diaz M. O. (1992): Multichain structure of the interferon α-2 receptor on hematopoietic cells. J. Immunol., 148, 2126-2132.
12. Colamonici O. R., Uyttendaele H., Domanski P., Van H. and Krolewski J. J. (1994): p135tyk2 an interferon-dependent tyrosine kinase, is physically associated with an interferon receptor. J. Biol. Chem., 269, 3518-3522.
13. Colamonici O. R., Yan H., Domanski P., Handa R., Smalley D., Mullerman J., Witte M., Krishnan K. and Krolewski J. J. (1994): Direct binding and tyrosine phosphorylation of the a subunit (cloned subunit) of the type I IFN receptor and the p135tyk2 tyrosine kinase. Mol. Cell Biol., 14, 8133-8142.
14. Crespo P., Schuebel K. E., Ostrom A. A., Gutkind J. S. and Bustelo X. R. (1997): Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature, 385, 169-172.
15. Darnell J. E. Jr. (1997): Stats and gene regulation. Science, 277, 1630-1635.
16. Darnell J. E. Jr. (1998): Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res., 18, 549-554.
17. Darnell J. E. Jr., Kerr I. M and Stark G. R. (1994): Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins. Science, 264, 1415-1420.
18. Deak M., Clifton A. D., Lucocq J. M. and Alessi D. R. (1998): Mitogen and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38 and may mediate activation of CREB. EMBO. J., 17, 4426-4441.
19. Deb D. K., Sassano A., Lekmine F., Majchrzak B., Verma A., Kambhampati S., Uddin S., Rahman A., Fish E. N. and Platanias L. C. (2003): Activation of protein kinase Cδ by IFN-γ. J. Immunol., 171, 267-273.
20. Decker T. and Kovarik P. (2000): Serine phosphorylation of Stats. Oncogene, 19, 2628-2637.
21. Diaz M. O., Pomycala H., Bohlander S., Maltepe E., Malik K., Brownstein B. and Olopade O. I. (1994): Structure of the human type I interferon gene cluster determined from a YAC clone contig. Genomics, 22, 540-552.
22. Domanski P., Witte M., Kellum M., Rubinstein M., Hackett R., Pitha P. and Colamonici O. R. (1995): Cloning and expression of a long form of the β subunit of the interferon α/β receptor that is required for signaling. J. Biol. Chem., 270, 21606-21611.
23. Dong C., Davis R. J. and Flavell R. A. (2002): MAP kinases in the immune response. Annu. Rev. Immunol., 20, 55-72.
24. English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S. and Cobb M. H. (1999): New insights into the control of MAP kinase pathways. Exp. Cell. Res., 253, 255-270.
25. Ferrari S. and Thomas G. (1994): S6 phosphorylation and the p70s6k/p85s6k. Crit. Rev. Biochem. Mol. Biol., 29, 385-413.
26. Fish E. N., Uddin S., Korkmaz M., Majchrzak B., Druker B. J. and Platanias L. C. (1999): Activation of a CrkL-Stat5 signaling complex by type I interferons. J. Biol. Chem., 274, 571-573.
27. Gingras A. C., Kennedy S. G., O' Leary M. A., Sonenberg N. and Hay N. (1998): 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev., 12, 502-513.
28. Gingras A. C., Raught B., Gygi S. P., Niedzwiecka A., Miron M., Burley S. K., Polakicwicz R. D., Wyslouch-Cicszynska A., Aebersold R. and Sonenberg N. (2001): Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev., 15, 2852-2864.
29. Goh K. C., Haque S. J. and Williams B. R. (1999): p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO. J., 18, 5601-5608.
30. Gringhuis S. I., De Leij L. F., Coffer P. J. and Vellenga E. (1998): Signaling through CD5 activates a pathway involving phosphatidylinositol 3′-kinase, Vav, and Rac1 in human mature T-lymphocytes. Mol. Cell. Biol., 18, 1725-1735.
31. He Y. and Katze M. G. (2002): To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunol., 15, 95-119.
32. Horvath C. M. (2000): STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci., 25, 496-502.
33. Ihle J. N. (1995): The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol., 6, 1-35.
34. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Thierfelder W. E., Kreider B. and Silvennoinen O. (1994): Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci., 19, 222-227.
35. Kovarik P., Mangold M., Ramsauer K., Heidari H., Steinborn R., Zotter A., Levy D. E., Muller M. and Decker T. (2001): Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO. J., 20, 91-100.
36. Kovarik P., Stoiber D., Eyers P. A., Menghini R., Neininger A., Gaestel M., Cohen P. and Decker T. (1999): Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc. Natl. Acad. Sci. USA, 96, 13956-13961.
37. Kyriakis J. M. and Avruch J. (1996): Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271, 24313-24316.
38. Lekmine F., Sassano A., Uddin S., Majchrzak B., Miura O., Druker B.J., Fish E. N., Imamoto A. and Platanias L. C. (2002): The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the Small G-protein Rap1. Biochem. Biophys. Res. Commun., 291, 744-750.
39. Lekmine F., Uddin S., Sassano A., Parmar S., Majchrzak B., Sonenberg N., Hay N., Fish E. N. and Platanias L. C. (2003): Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J. Biol. Chem., 278, 27772-27780.
40. Levy D. E. and Darnell J. E. Jr. (2002): Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol., 3, 651-62.
41. Li Y., Sassano A., Majchrzak B., Deb D. K., Levy D. E., Gaestel M., Nebreda A. R., Fish E. N. and Platanias L. C. (2004): Role of p38α map kinase in type I interferon signaling. J. Biol. Chem., 279, 970-979.
42. Lutfalla G., Holland S. J., Ginato E., Monneron D., Reboul J., Rogers N. C., Smith J. M., Stark G. R., Gardiner K., Mogensen K. E., Kerr I. M. and Uzé G. (1995): Mutant U5A cells are complemented by an interferon-αβ-receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO. J., 14, 5100-5108.
43. Mayer I. A., Verma A., Grumbach I. M., Uddin S., Lekmine F., Ravandi F., Majchrzak B., Fujita S., Fish E. N. and Platanias L. C. (2001): The p38 Map kinase pathway mediates the growth inhibitory effects of IFNα in BCR-ABL expressing cells. J. Biol. Chem., 276, 28570-28577.
44. Vav is associated to the IFNα/β receptor and contributes to the antiproliferative effect of IFNα in megakaryocytic cell lines. Oncogene, 19, 387-394.
45. Mogensen K. E., Lewerenz M., Reboul J., Lutfalla G. and Uze G. (1999): The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res., 19, 1069-1098.
46. Müller M., Briscoe J., Laxton C., Guschin D., Ziemecki A., Silvennoinen O., Harpur A. G., Barbieri G., Witthun B. A., Schindler C., Pellegrini S., Wilks A. F., Ihle J. N., Stark G. R. and Kerr I. M. (1993): The protein tyrosine kinase JAK-1 complements defects in interferon α/β and δ signal transduction. Nature, 366, 129-135.
47. Myers M., Sun X. and White M. F. (1994): The IRS-signaling system. Trends Biochem. Sci., 19, 289-294.
48. 2+ and CaMKII for Stal1 Ser-727 phosphorylation in response to IFN-γ. Proc. Natl. Acad. Sci. USA, 99, 5971-5976.
49. Novick D., Cohen B. and Rubinstein M. (1994): The human interferon α/β receptor: Characterization and molecular cloning. Cell, 77, 391-400.
50. Parmar S. and Platanias L. C. (2003): Interferons. Mechanisms of action and clinical applications. Curr. Opin. Oncol., 15, 431-439.
51. Pestka S. (1986): Interferon standards and general abbreviations. Methods Enzymol., 119, 14-23.
52. Pestka S. (1997): The human interferon α species and hybrid proteins. Semin. Oncol., 24, S9-4-S9-17.
53. Pestka S. (2000): The human interferon α species and receptors. Biopolymers, 55, 254-287.
54. Pestka S., Langer J. A., Zoon K. C. and Samuel C. E. (1987): Interferons and their actions. Annu. Rev. Biochem., 56, 727-777.
55. Platanias L. C. (2003): Map kinase signaling pathways and hematologic malignancies. Blood, 101, 4667-4679.
56. Platanias L. C. (2003): The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol. Ther., 98, 129-142.
57. Platanias L. C. and Colamonici O.R. (1992): Interferon α induces rapid tyrosine phosphorylation of the subunit of its receptor. J. Biol. Chem., 267, 24053-24057.
58. Platanias L. C. and Fish E.N. (1999): Signaling pathways activated by interferons. Exp. Hematol., 27, 1583-1592.
59. Platanias L. C., Pfeffer L. M., Barton K., Vardiman J. W., Colomb H. M. and Colamonici O. R. (1992): Expression of the IFNα receptor in hairy cell leukemia cells. Br. J. Haematol., 82, 541-546.
60. Platanias L. C., Pfeffer L. M., Cruciani R. and Colamonici O. R. (1993): Characterization of the α-subunit of the IFNα receptor. Evidence for N- and O-linked glycosylation and association with other surface proteins. J. Immunol., 150, 3382-3388.
61. Platanias L. C. and Sweet M. E. (1994): Interferon α-induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J. Biol. Chem., 269, 3143-3146.
62. Platanias L. C., Uddin S. and Colamonici O. R. (1994): Tyrosine phosphorylation of the α and β subunits of the type I interferon receptor. Interferon β selectively induces tyrosine phosphorylation of a α subunit-associated protein. J. Biol. Chem., 27, 17761-17764.
63. Platanias L. C., Uddin S., Domanski P. and Colamonici O. R. (1996): Differences in signaling between interferon α and β. Interferon β selectively induces the interaction of the α and βL subunits of the type I interferon receptor. J. Biol. Chem., 271, 23630-23633.
64. Platanias L. C., Uddin S., Yetter A., Sun X.-J. and White M. F. (1996): The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J. Biol. Chem., 271, 278-282.
65. Prejean C. and Colamonici O. R. (2000): Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling. Semin. Cancer Biol., 10, 83-92.
66. Rane S. G. and Reddy E. P. (2000): Janus kinases: components of multiple signaling pathways. Oncogene, 19, 5662-5679.
67. Rincon M., Flavell R. A. and Davis R. J. (2001): Signal transduction by MAP kinases in T lymphocytes. Oncogene, 20, 2490-2497.
68. Roberts R. M., Liu L., Guo Q., Leaman D. and Bixby J. (1998): The evolution of the type I interferons. J. Interferon Cytokines Res., 18, 805-816.
69. Salojin K. V., Zhang J. and Delovitch T. L. (1999): TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol., 163, 844-853.
70. Sattler M. and Salgia R. (1998): Role of the adapter protein CrkL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells. Leukemia, 12, 637-644.
71. Schaeffer H. J. and Weber M. J. (1999): Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol., 19, 2435-2444.
72. Sen G. C. (2001): Viruses and interferons. Annu. Rev. Microbiol., 55, 255-281.
73. Silvennoinen O., Ihle J. N., Schlessinger J. and Levy D. E. (1993): Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature, 366, 583-585.
74. Soloaga A., Thomson S., Wiggin G. R., Rampersaud N., Dyson M. H., Hazzalin C. A., Mahadevan L. C. and Arthur J. S. (2003): MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO. J., 22, 2788-2797.
75. Stark G. R., Kerr I. M., Williams B. R. G., Silverman R. H. and Screiber R. D. (1998): How cells respond to interferons. Annu. Rev. Biochem., 67, 227-264.
76. Thompson S., Clayton A. L., Hazzalin C. A., Rose S., Barratt M. J. and Mahadevan L. C. (1999): The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO. J., 18, 4779-4793.
77. Thomson S., Mahadevan L. C. and Clayton A. L. (1999): MAP kinase-mediated signaling to nucleosomes and immediate-early gene induction. Semin. Cell Dev. Biol., 10, 205-214.
78. Uddin S., Alsayed Y., Grumbach I., Woodson J. and Platanias L. C. (1999): Cellular pathways activated by interferons in hematopoietic cells. Haema, 2, 192-197.
79. Uddin S., Chamdin A. and Platanias L. C. (1995): Interaction of the transcriptional activator Stat-2 with the type I IFN receptor. J. Biol. Chem., 270, 24627-24630.
80. Uddin S., Fish E. N., Sher D., Gardziola C., Colamonici O. R., Kellum M., Pitha P., White M. F. and Platanias L. C. (1997): The IRS-pathway operates distinctively from the Slat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or IFNα receptors. Blood, 90, 2574-2582.
81. Uddin S., Fish E. N., Sher D. A., Gardziola C., White M. F. and Platanias L. C. (1997): Activation of the phosphatidylinositol 3′-kinase serine kinase by IFNα. J. Immunol., 158, 2390-2397.
82. Uddin S., Lekmine F., Sassano A., Rui H., Fish E. N., Platanias L. C. (2003): Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem. Biophys. Res. Commun., 308, 325-330.
83. Uddin S., Majchrzak B., Wang P. C., Modi S., Khan M. K., Fish E. N. and Platanias L. C. (2000): Interferon α-dependent activation of the phosphatidylinositol 3-′kinase serine kinase requires engagement of the IRS- but not the Stat-pathway. Biochem. Biophys. Res. Commun., 270, 158-162.
84. Uddin S., Majchrzak B., Woodson J., Arunkumar P., Alsayed Y., Pine R., Young P. R., Fish E. N. and Platanias L. C. (1999): Activation of the p38 Map kinase by type I IFNs. J. Biol. Chem., 274, 30127-30131.
85. Uddin S., Sassano A., Deb D. K., Verma A., Majchrzak B., Rahman A., Malik A. B., Fish E. N. and Platanias L. C. (2002): Protein kinase C-δ (PKC-δ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem., 277, 14408-14416.
86. Uddin S., Sharma N., Majchrzak B., Mayer I., Lekmine F., Young P. R., Bokoch G. M., Fish E. N. and Platanias L. C. (2000): The Rac1/p38 Map kinase pathway is required for interferon α-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem., 275, 27634-27640.
87. Uddin S., Sweet M. E., Colamonici O. R., Krolewski J. J. and Platanias L. C. (1997): The vav proto-oncogene product interacts with the Tyk-2 tyrosine kinase. FEBS Lett., 403, 31-34.
88. Uddin S., Yenush L., Sun X.-J., Sweet M. E., White M. F. and Platanias L. C. (1995): Interferon α engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol. Chem., 270, 15938-15941.
89. Uzé G., Lutfalla G. and Gresser I. (1990): Genetic transfer of a functional human interferon receptor into mouse cells: cloning and expression of its cDNA. Cell, 60, 225-232.
90. Uzé G., Lutfalla G., Mongensen K. E. (1995): α and β interferons and their receptor and their friends and relations. J. Interferon Res., 15, 3-26.
91. Verma A., Deb D. K., Sassano A., Uddin S., Varga J. Wickrema A. and Platanias L. C. (2002): Activation of the p38 Map kinase pathway mediates the suppressive effects of type I interferons and transforming growth factor β on normal hematopoiesis. J. Biol. Chem., 277, 7726-7735.
92. Verma A., Kambhampati S., Parmar S. and Platanias L. C. (2003): Jak family of kinases in cancer. Cancer Metastasis Rev., 22, 423-434.
93. Wen Z. and Darnell J. E. Jr. (1997): Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res., 25, 2062-2067.
94. Wen Z., Zhong Z., Darnell J. E. Jr. (1995): Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell, 82, 241-250.
95. Yeh T. C. and Pellegrini S. (1999): The Janus kinase family of protein tyrosine kinases and their role in signaling. Cell Mol. Life Sci., 55, 1523-1534.
96. Zhang J. J., Zhao Y., Chait B. T., Lathem W. W., Ritzi M., Knippers R. and Darnell J. E. Jr. (1998): Scr727-dependent recruitment of MCM5 by Static in IFN-γ-induced transcriptional activation. EMBO J., 17, 6963-6971.
97. Zhu X., Wen Z., Xu L. Z. and Darnell J. E. Jr. (1997): Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell. Biol., 17, 6618-6623.